| ELCRX | RGAHX | ELCRX / RGAHX | |
| Total Expense Ratio | 1.28 | 0.44 | 291% |
| Annual Report Gross Expense Ratio | 1.28 | 0.44 | 291% |
| Fund Existence | 16 years | 10 years | - |
| Gain YTD | 14.735 | 19.104 | 77% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 464M | 339B | 0% |
| Annual Yield % from dividends | 0.00 | 0.44 | - |
| Returns for 1 year | 6.30 | 7.14 | 88% |
| Returns for 3 years | 56.12 | 62.15 | 90% |
| Returns for 5 years | 25.25 | 32.51 | 78% |
| Returns for 10 years | 96.82 | 93.22 | 104% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SEPW | 31.70 | 0.06 | +0.19% |
| AllianzIM U.S. Large Cp Buffer20 Sep ETF | |||
| VNIE | 24.20 | N/A | N/A |
| Vontobel International Equity Active ETF | |||
| JBBB | 47.71 | -0.01 | -0.02% |
| Janus Henderson B-BBB CLO ETF | |||
| PSQO | 20.78 | -0.03 | -0.12% |
| Palmer Square Credit Opportunities ETF | |||
| IBBQ | 28.22 | -0.17 | -0.59% |
| Invesco Nasdaq Biotechnology ETF | |||